Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bactek-O for adults with non-cystic fibrosis bronchiectasis
ACTRN12618001171202Phase 2Completed
- Sponsor
- Health Research Council of New Zealand
- Start
- Dec 2018
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bronchiectasis comparing Bactek-O with Placebo (2 arms). Primary endpoint: Sputum procalcitonin. Started Dec 2018; status: completed.
02
Drugs
MV130
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on ACTRN12618001171202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001171202.